Aptilon Corp – Filings and Transcripts

OTC: APTOF
Share price (4/27/26): $1.71
Market cap (4/27/26): $341 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Going private transaction – amended

Registration withdrawal request

Going private transaction – amended

Going private transaction – amended

Going private transaction – amended

Ownership Filter

Bleichroeder LP

Bleichroeder LP

Bleichroeder LP

Bleichroeder LP

Hanmi Pharmaceutical Co., Ltd.

News Filter

Shareholder Vote Results

Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights

Material Definitive Agreement, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement

Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement With Hanmi Pharmaceutical

Proxies Filter

Proxy related to merger

Preliminary revised proxy

Preliminary revised proxy

Preliminary revised proxy

Preliminary proxy related to merger

Other Filter

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC